
Editas Medicine, Inc.
Editas Medicine, Inc. (EDIT)
WebsitePrice
Market cap
Next catalystDosing planned in 2026; New Zealand participation subject to approvalEDIT-401 — Strive · Trial initiationSEC filing ↗
Cash
Chart & Events
Core Clinical
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
Other pipelines
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved